Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Retail Partner ApS to distribute Acetium® lozenge in Danmark and Sweden

Biohit

Biohit Oyj Press release, September 3, 2018 at 10.00 p.m. local time (EET)

Biohit Oyj and Retail partner ApS have signed an agreement for the distribution of the smoking cessation product Acetium lozenge in Danmark and Sweden.

The new Acetium lozenge is an effective and safe product that helps quit smoking without nicotine and it has no side effects. Acetium lozenge eliminates cigarette smoke-derived carcinogenic acetaldehyde in the saliva during smoking. According to the clinical trial, Acetium lozenge helps to quit smoking (1-3).

CEO Frode Telstad, Retail partner ApS:”We at Retail Partner are proud to be chosen as BIOHIT’s future partner and distributor in Denmark and Sweden. As a distributor, already focusing on personal and health care categories, we believe we have found a perfect fit to our existing portfolio. Over the last many years Scandinavians have been able to reduce smoking to a lower level, and with the launch of Acetium we are committed in helping this development to continue also in the years to come.”

CEO Semi Korpela, Biohit Oyj:”With this agreement Retail Partner ApS S.A. obtains the rights to distribute Acetium lozenge in Danmark and Sweden. Acetium lozenge offers a side effect-free and safe option to abandon this unhealthy addiction. Smoking-related diseases represent a major health burden in Western countries.”


Additional information: 
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

1. Syrjänen K et al. Slow-release L-cysteine (Acetium®) lozenge is an effective new method in smoking cessation. A randomized, double-blind, placebo-controlled intervention. Anticancer Res 2017;37:3639-3648.

2. https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=785626&lang=en

3. http://www.biohithealthcare.com/products/acetaldehyde-binding-products/products/25/acetium-lozenge



Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com


Retail Partner ApS in brief

Retail Partner ApS is a Nordic distributor company established in Copenhagen, Denmark. Our ambition is to set up long-term partnerships with branded

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.